Amphastar Pharmaceuticals, Inc AMPH

HaseebKhan_90

Notes: * Strong up trend since late 2021 * Great earnings track record * Building a base for the past ~4 months * Building a pivot area around $37.8 for the past three weeks * Bounced off of the 50 day line with higher than average volume * Has been using the 50 day line as a dynamic level of support for the past month or so Technicals: Sector: Healthcare -...

ImHardik88 Pro Updated 

it looks like strong buying is going on since last 1 week in this bloodbath time. interesting thing to watch ahead

vmreyesa Pro Updated 

Buy point: 35.20 Stop: 33.25 Risk:5.5% Avg Cost: 35.8 I was late to the trade so couldn't fill up my full defensive position. (111.25 Shares, 283.7 USD Risk) Im now 8% invested on 6 pilot positions.

NicksAnalysis Pro Updated 

Amphastar Pharmaceuticals ( NASDAQ:AMPH ) is currently at historical resistance after reaching a new high today at $34.42. It's now above the average analyst target ($28.50 as of 3/7/2022) and insiders have sold $2.2 million in the past 2 months. Earnings on March 10th. The float is near 37 million with a 5.5% short interest. It is at "risk" for a...

jjmatsjr Pro+

High and tight flag with back to back shakeouts. Potential to break out of a huge base.

SurfStalker Premium

Uptrend, setting up www.tradingview.com

kennzo Pro

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use....

RocketTickers

AMPH: Amphastar Pharmaceuticals, Inc. 2021-05-03 06:00:00 Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

RocketTickers

AMPH: Amphastar Pharmaceuticals, Inc. 2020-06-09 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial

RocketTickers

AMPH: Amphastar Pharmaceuticals, Inc. 2020-04-27 06:00:10 Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

RocketTickers

AMPH: amphastar pharma 2018-05-14 06:00:06 Detected possible FDA approval

tradeyay Updated 

Little late on this one but... I like how its relatively strong against the market and what volume is suggesting...fingers crossed

lukatrade

Trading from the day open with target at 21.64 with stop loss at 18.03

Cetan Premium Updated 

Neutral Swing Short from 15 to 13.80-14.00 support zone. If 13.80-14.00 support is held , take profits and long to 16.50 price target. If 13.80-14.00 support is broken , maintain/add to your short position, cover at 12.50 price target. Bullish Swing Buy at ~13 if support is held . Sell at ~16. Do your due diligence. Trade...

JPMorgains

Looks coiled up.

jofansiwork

AMPH in Day time frame is following the weinstein steps. we are in Step 1 , time to enter for a long run until entering step3.